Nonetheless, our study opens door for future exploration to determine whether inhibition of BMP/Smad1 signaling by small-molecule inhibitors, such as dorsomorphin [44], shortly after stroke would confer neuroprotection, or whether for high-risk patients administering a selective BMP/Smad inhibitor preemptively would serve as a preventative measure against stroke. Here, SMAD1 is linked to stroke disorder.